OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 04/26/2024
Week ended 04/26/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 04/26/2024
- The Week’s Closed Equity Deals
- On April 24, 2024, nDatalyze Corp (NDAT: CSE)(NDATF: OTC), a Calgary-based health tech company that owns YMI, a machine learning/AI-based system designed to lower misdiagnosis of common mental conditions, closed a private placement of 1M common shares for gross proceeds of $.15M.
- NDAT recently closed an acquisition of Mindbalance, geared towards entry to the U.S. market.
- The imputed market cap and enterprise value of NDAT, based on the equity sale, are approximately $6.57M and $5.71fM, respectively.
Public vs. Private Raises:
- The week’s only capital raise by NDAT trades on the CSE in Canada and OTC in the U.S.
Equity vs. Debt Cap Raises:
- Equity accounted for 100% of this week’s funds raised.
Week ended 04/26/2024
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 04/26/2024
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 04/26/2024
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.